Finance

Lists
524558:BOM
Neuland Laboratories Ltd
₹20,185.70
-0.68%
(-137.35) 1D
Nov 11, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524558...
Open
₹20,320.00
High
₹20,384.90
Low
₹19,800.35
Mkt. cap
259.23B
Avg. vol.
4.43K
Volume
4.36K
Dividend
0.17%
Quarterly dividend
₹8.50
Ex-dividend date
Jul 24, 2026
P/E ratio
57.23
52-wk high
₹24,235.05
52-wk low
₹11,500.00
EPS
₹352.71
Shares outstanding
12.83M
No. of employees
2K
Open
₹20,320.00
High
₹20,384.90
Low
₹19,800.35
Mkt. cap
259.23B
Avg. vol.
4.43K
Volume
4.36K
Dividend
0.17%
Quarterly dividend
₹8.50
Ex-dividend date
Jul 24, 2026
P/E ratio
57.23
52-wk high
₹24,235.05
52-wk low
₹11,500.00
EPS
₹352.71
Shares outstanding
12.83M
No. of employees
2K
News stories
From web sources and news partners
About Neuland Laboratories Ltd
CEO-
Employees2.18K
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
4.40B
7.76B
6.42B
4.50B
Cost of goods sold
2.44B
3.21B
2.69B
2.09B
Cost of revenue
2.44B
3.21B
2.69B
2.09B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
888.32M
1.00B
1.06B
1.02B
Operating expense
1.43B
1.68B
1.76B
1.72B
Total operating expenses
3.86B
4.89B
4.45B
3.81B
Operating income
532.13M
2.88B
1.96B
687.90M
Other non operating income
80.52M
-229.59M
84.92M
74.95M
EBT including unusual items
544.75M
2.87B
1.98B
689.78M
EBT excluding unusual items
544.75M
2.83B
1.98B
689.78M
Income tax expense
139.04M
748.22M
501.74M
173.53M
Effective tax rate
25.52%
26.03%
25.36%
25.16%
Other operating expenses
301.24M
425.70M
432.98M
414.77M
Net income
405.72M
2.13B
1.48B
516.25M
Net profit margin
9.23%
27.40%
23.02%
11.48%
Earnings per share
31.62
165.76
115.10
40.24
Interest and investment income
-
100.55M
-
-
Interest expense
-67.90M
-19.54M
-69.72M
-73.07M
Net interest expenses
-67.90M
81.01M
-69.72M
-73.07M
Depreciation and amortization charges
239.20M
250.89M
265.63M
287.71M
EBITDA
680.40M
3.07B
2.16B
964.57M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps